LDL-C target achievement after adding evinacumab in 2 patients with autosomal recessive hypercholesterolemia. (PubMed, J Clin Lipidol) - Mar 4, 2026 - "These cases demonstrate a marked and clinically meaningful LDL-C-lowering effect of evinacumab in ARH, supporting its use as an effective LDL-R-independent therapeutic option."
Journal • Atherosclerosis • Cardiovascular • Dyslipidemia • Familial Hypercholesterolemia • Genetic Disorders • Homozygous Familial Hypercholesterolemia • Metabolic Disorders
|
|
Antonia Albertí; Cesare Riccardo Sirtori; Chiara Moschetti; Chiara Pavanello; Francesco Vicari; Giuliana Germana Mombelli; Laura Calabresi
|